Please use this identifier to cite or link to this item:
Title: Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling
Authors: Adav, Sunil Shankar
Sze, Siu Kwan
Keywords: Dementia
Alzheimer disease
Issue Date: 2016
Source: Adav, S. S., & Sze, S. K. (2016). Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling. Molecular Brain, 9, 92-.
Series/Report no.: Molecular Brain
Abstract: Dementia is a syndrome associated with a wide range of clinical features including progressive cognitive decline and patient inability to self-care. Due to rapidly increasing prevalence in aging society, dementia now confers a major economic, social, and healthcare burden throughout the world, and has therefore been identified as a public health priority by the World Health Organization. Previous studies have established dementia as a ‘proteinopathy’ caused by detrimental changes in brain protein structure and function that promote misfolding, aggregation, and deposition as insoluble amyloid plaques. Despite clear evidence that pathological cognitive decline is associated with degenerative protein modifications (DPMs) arising from spontaneous chemical modifications to amino acid side chains, the molecular mechanisms that promote brain DPMs formation remain poorly understood. However, the technical challenges associated with DPM analysis have recently become tractable due to powerful new proteomic techniques that facilitate detailed analysis of brain tissue damage over time. Recent studies have identified that neurodegenerative diseases are associated with the dysregulation of critical repair enzymes, as well as the misfolding, aggregation and accumulation of modified brain proteins. Future studies will further elucidate the mechanisms underlying dementia pathogenesis via the quantitative profiling of the human brain proteome and associated DPMs in distinct phases and subtypes of disease. This review summarizes recent developments in quantitative proteomic technologies, describes how these techniques have been applied to the study of dementia-linked changes in brain protein structure and function, and briefly outlines how these findings might be translated into novel clinical applications for dementia patients. In this review, only spontaneous protein modifications such as deamidation, oxidation, nitration glycation and carbamylation are reviewed and discussed.
DOI: 10.1186/s13041-016-0272-9
Schools: School of Biological Sciences 
Rights: © 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SBS Journal Articles

Files in This Item:
File Description SizeFormat 
art%253A10.1186%252Fs13041-016-0272-9.pdf2.72 MBAdobe PDFThumbnail

Citations 10

Updated on Sep 25, 2023

Web of ScienceTM
Citations 10

Updated on Sep 22, 2023

Page view(s) 50

Updated on Sep 26, 2023

Download(s) 50

Updated on Sep 26, 2023

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.